Raymond James Financial Services Advisors, Inc. Repligen Corp Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 3,325 shares of RGEN stock, worth $478,168. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,325
Previous 3,219
3.29%
Holding current value
$478,168
Previous $405,000
21.98%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding RGEN
# of Institutions
488Shares Held
54.2MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.09 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$919 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$725 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$234 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$204 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.98B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....